Mir22 can act as either a tumor suppressor or an oncomiR, depending upon the context, and its expression has been shown to increase with aging in hearts (Huang and Wang, 2018; Wang et al., 2017; Jazbutyte et al., 2013). The gene discussed is MIR22; the disease is neoplasm.